News QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 15:42:11 20/04/2026 BST			5-day change	1st Jan Change
13.17 ^USD	+3.62%		-18.60%	-54.17%

01:26pm	QuidelOrtho Completes Acquisition of LEX Diagnostics for $100 Million	MT
04-16	Top Midday Decliners	MT

All News

01:26pm	QuidelOrtho Completes Acquisition of LEX Diagnostics for $100 Million	MT
12:13pm	QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics	PR
04-16	Top Midday Decliners	MT
04-15	QuidelOrtho announces preliminary revenue for the first quarter 2026 and provides update on full-year 2026 guidance	RE
04-15	QuidelOrtho Expects Q1 Revenue of $615 Million-$620 Million; Shares Fall After Hours	MT
04-15	QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance	PR
04-15	Quidelortho Corporation Provides Earnings Guidance for First Quarter Ended March 29, 2026	CI
04-10	UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating	MT
03-24	QuidelOrtho Corporation Announces Chief Legal Officer Changes	CI
03-24	Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer	PR
02-19	QuidelOrtho : Annual Report for Fiscal Year Ending December 28, 2025 (Form 10-K)	PU
02-18	QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference	PR
02-16	QuidelOrtho Corporation Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio	CI
02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI
02-12	UBS Adjusts QuidelOrtho Price Target to $30 From $35, Maintains Neutral Rating	MT
02-12	QuidelOrtho Corporation, Q4 2025 Earnings Call, Feb 11, 2026
02-11	QuidelOrtho Q4 Earnings Fall, Revenue Rises; Issues Guidance	MT
02-11	QuidelOrtho: Q4 Earnings Snapshot	AQ
02-11	Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q4 Revenue $723.6M, vs. FactSet Est of $700.7M	MT
02-11	Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q4 Adjusted EPS $0.46 per Share, vs. FactSet Est of $0.42	MT
02-11	QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results	PR
02-11	Joseph M. Busky to Retire as Chief Financial Officer of QuidelOrtho Corporation, Effective June 30, 2026	CI
02-11	QuidelOrtho Corporation Provides Earnings Guidance for the Fiscal Year 2026	CI
02-11	QuidelOrtho Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 28, 2025	CI
02-05	QuidelOrtho Corp Announces Departure of Director Matthew W. Strobeck	CI